Inicio › Carcinoma de células escamosas de cabeza y cuello › Tennessee
Ensayos clínicos de Carcinoma de células escamosas de cabeza y cuello en Tennessee
43 estudios sobre Carcinoma de células escamosas de cabeza y cuello buscan participantes en Tennessee.
Ciudades en Tennessee
Texto oficial del estudio (inglés)
FORTIFI-HN01: A Study of Ficerafusp Alfa (BCA101) or Placebo in Combination With Pembrolizumab in First-Line PD-L1-pos, R or M HNSCC
- Site#0126, Nashville
- Site #0116, Nashville
ReclutandoFase 2/3
Edades de 18 en adelante · Todos los sexos · Actualizado el 2 oct 2026 · NCT06788990A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
- Sarah Cannon Research Institute, Nashville
- Tennessee Oncology PLLC, Nashville
ReclutandoFase 1
Edades de 18 en adelante · Todos los sexos · Actualizado el 2 oct 2026 · NCT06465069Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
- Exelixis Clinical Site #3, Nashville
ReclutandoFase 1
Edades de 18 en adelante · Todos los sexos · Actualizado el 1 oct 2026 · NCT05176483A Study to Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid Tumors
- Sarah Cannon Research Institute - Pharmacy, Nashville
- SCRI Oncology Partners, Nashville
ReclutandoFase 1
Edades de 18 en adelante · Todos los sexos · Actualizado el 1 oct 2026 · NCT07090499A Study of NT-175 in Adult Participants With Advanced Malignancies That Are Positive for HLA-A*02:01 and the TP53 R175H Mutation
- Research Site, Nashville
ReclutandoFase 1
Edades de 18 en adelante · Todos los sexos · Actualizado el 29 sept 2026 · NCT05877599A Study of Amivantamab in Addition to Standard of Care Agents (SOC) Compared With SOC Alone in Participants With Recurrent/Metastatic Head and Neck Cancer
- Tennessee Cancer Specialists, Knoxville
- Vanderbilt University Medical Center, Nashville
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 25 sept 2026 · NCT07276399Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis
- Vanderbilt University Medical Center, Nashville
ReclutandoFase 1/2
Edades de 18 en adelante · Todos los sexos · Actualizado el 24 sept 2026 · NCT06047379Testing What Happens When an Immunotherapy Drug (Pembrolizumab) is Given by Itself Compared to the Usual Treatment of Chemotherapy With Radiation After Surgery for Recurrent Head and Neck Squamous Cell Carcinoma
- Vanderbilt University/Ingram Cancer Center, Nashville
ReclutandoFase 2
Edades de 18 a 79 · Todos los sexos · Actualizado el 22 sept 2026 · NCT04671667Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors
- Sarah Cannon - Tennessee Oncology, Nashville
ReclutandoFase 1
Edades de 18 en adelante · Todos los sexos · Actualizado el 21 sept 2026 · NCT05983432Study of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rα Binding, in Patients With Unresectable Locally Advanced or Metastatic Cancer
- Sarah Cannon Research Institute, Nashville
ReclutandoFase 1/2
Edades de 18 en adelante · Todos los sexos · Actualizado el 18 sept 2026 · NCT05267626A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations
- Sarah Cannon Nashville, Nashville
ReclutandoFase 1/2
Edades de 18 en adelante · Todos los sexos · Actualizado el 17 sept 2026 · NCT07109726A Phase 1 Study of EPI-326 in EGFR-mutant NSCLC and HNSCC
- Sarah Cannon and HCA Research Institute, Nashville
ReclutandoFase 1
Edades de 18 en adelante · Todos los sexos · Actualizado el 10 sept 2026 · NCT07462377A Longitudinal Multi-Omic Biomarker Profiling Study of Patients With Head & Neck Squamous Cell Carcinoma (HNSCC)
- Vanderbilt University, Nashville
ReclutandoEstudio observacional
Edades de 18 en adelante · Todos los sexos · Actualizado el 3 sept 2026 · NCT06163534A Study to See if Giving Fianlimab and Cemiplimab Together is Better Than Cemiplimab Alone at Treating Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
- University of Tennessee Medical Center, Knoxville
- Vanderbilt-Ingram Cancer Center, Nashville
ReclutandoFase 2
Edades de 18 en adelante · Todos los sexos · Actualizado el 21 ago 2026 · NCT06769698A Phase 1 Study of NRM-823 in Participants With Locally Advanced or Metastatic Refractory Solid Tumors
- Normunity Investigational Site, Nashville
ReclutandoFase 1
Edades de 18 en adelante · Todos los sexos · Actualizado el 18 ago 2026 · NCT07182149A Study of BMS-986340 as Monotherapy and as Combination Therapy in Participants With Advanced Solid Tumors
- Vanderbilt University Medical Center, Nashville
ReclutandoFase 1/2
Edades de 18 en adelante · Todos los sexos · Actualizado el 17 ago 2026 · NCT04895709Comparing Sentinel Lymph Node (SLN) Biopsy With Standard Neck Dissection for Patients With Early-Stage Oral Cavity Cancer
- Methodist Hospital, Memphis
- University of Tennessee Health Science Center, Memphis
- Vanderbilt University/Ingram Cancer Center, Nashville
ReclutandoFase 2/3
Edades de 18 en adelante · Todos los sexos · Actualizado el 17 ago 2026 · NCT04333537Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the Usual Chemoradiation Therapy for Patients With Head and Neck Cancer
- Baptist Memorial Hospital and Cancer Center-Collierville, Collierville
- University of Tennessee - Knoxville, Knoxville
- Baptist Memorial Hospital and Cancer Center-Memphis, Memphis
ReclutandoFase 2
Edades de 18 en adelante · Todos los sexos · Actualizado el 17 ago 2026 · NCT06532279SMP-3124LP in Adults With Advanced Solid Tumors
- SCRI Oncology Partners, Nashville
- Vanderbilt-Ingram Cancer Center, Nashville
ReclutandoFase 1/2
Edades de 18 en adelante · Todos los sexos · Actualizado el 12 ago 2026 · NCT06526819A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)
- Erlanger Health, Inc, Chattanooga
- The West Clinic, Germantown
- SCRI Oncology Partners, Nashville
ReclutandoFase 1/2
Edades de 18 en adelante · Todos los sexos · Actualizado el 5 ago 2026 · NCT06330064Window Trial of Fluorescently Labeled Panitumumab (Panitumumab-IRDye800) in Head and Neck Cancer
- Vanderbilt University Medical Center, Nashville
ReclutandoFase 1
Edades de 18 en adelante · Todos los sexos · Actualizado el 3 ago 2026 · NCT06819228A Study of Bispecific Antibody MCLA-158 in Patients With Advanced Solid Tumors
- The University Of Tennessee Health Science Center, Memphis
ReclutandoFase 1/2
Edades de 18 en adelante · Todos los sexos · Actualizado el 29 jul 2026 · NCT03526835A Phase 1 of CTX-8371 in Patients With Advanced Malignancies
- Tennessee Oncology, Nashville
ReclutandoFase 1
Edades de 18 en adelante · Todos los sexos · Actualizado el 28 jul 2026 · NCT06150664First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors
- The West Clinic, PLLC dba West Cancer Center, Germantown
- Sarah Cannon Research Institute, Nashville
ReclutandoFase 1/2
Edades de 18 en adelante · Todos los sexos · Actualizado el 7 jul 2026 · NCT05768139Safety and Feasibility of Nivolumab-IRDye800CW in Patients With Head and Neck Squamous Cell Carcinoma (HNSCC)
- Vanderbilt University Medical Center, Nashville
ReclutandoFase 1
Edades de 18 en adelante · Todos los sexos · Actualizado el 7 jul 2026 · NCT07460765A Study of Sigvotatug Vedotin in Advanced Solid Tumors
- US Oncology Research LLC, Nashville
ReclutandoFase 1
Edades de 18 en adelante · Todos los sexos · Actualizado el 6 jul 2026 · NCT04389632A Study of IDE034 in Adult Participants With Locally Advanced/Metastatic Solid Tumors Types
- SCRI Oncology Partners, Nashville
ReclutandoFase 1
Edades de 18 en adelante · Todos los sexos · Actualizado el 18 jun 2026 · NCT07503808A Study of Dostarlimab vs Placebo After Chemoradiation in Adult Participants With Locally Advanced Unresected Head and Neck Squamous Cell Carcinoma
- GSK Investigational Site, Chattanooga
- GSK Investigational Site, Germantown
- GSK Investigational Site, Nashville
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 26 may 2026 · NCT06256588Study Evaluating [18F]NOTA-ABY030 for Safety and Tolerability of Indeterminate Primary and/or Metastatic Disease in Head and Neck Squamous Cell Carcinoma
- Vanderbilt University Medical Center, Nashville
ReclutandoFase 1
Edades de 18 en adelante · Todos los sexos · Actualizado el 11 may 2026 · NCT07217028High-Resolution PET-CT Imaging for Surgical Margin Visualization
- Vanderbilt University Medical Center, Nashville
Reclutando
Edades de 18 en adelante · Todos los sexos · Actualizado el 8 may 2026 · NCT06915454(89Zr Panitumumab) With PET/CT for Diagnosing Metastases in Patients With Head and Neck Squamous Cell Carcinoma
- Vanderbilt University/Ingram Cancer Center, Nashville
ReclutandoFase 1
Edades de 19 en adelante · Todos los sexos · Actualizado el 8 may 2026 · NCT05747625Pilot Study of Bone Mineral Density Changes During Anti-PD-1 Immunotherapy
- Vanderbilt-Ingram Cancer Center, Nashville
Reclutando
Edades de 18 en adelante · Todos los sexos · Actualizado el 6 may 2026 · NCT07555210A Study of DB-1310 in Advanced/Metastatic Solid Tumors
- Tennessee Oncology, PLLC, Nashville
ReclutandoFase 1/2
Edades de 18 en adelante · Todos los sexos · Actualizado el 6 abr 2026 · NCT05785741Evaluating 111In Panitumumab for Nodal Staging in Head and Neck Cancer
- Vanderbilt University/Ingram Cancer Center, Nashville
ReclutandoFase 1
Edades de 19 en adelante · Todos los sexos · Actualizado el 5 mar 2026 · NCT05901545A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation
- Sarah Cannon Research Institute (SCRI) Oncology Partners, Nashville
- Vanderbilt University Medical Center, Nashville
ReclutandoFase 1
Edades de 18 en adelante · Todos los sexos · Actualizado el 13 feb 2026 · NCT06778863A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors
- Research Site 136, Nashville
ReclutandoFase 1/2
Edades de 18 en adelante · Todos los sexos · Actualizado el 21 nov 2025 · NCT05914116Tissue Sample Collection From Patients With Head and Neck Cancer and From Healthy Participants
- Vanderbilt-Ingram Cancer Center - Cool Springs, Nashville
- Vanderbilt-Ingram Cancer Center at Franklin, Nashville
- Veterans Affairs Medical Center - Nashville, Nashville
- y 1 más
ReclutandoEstudio observacionalSe aceptan voluntarios sanos
Edades de 18 en adelante · Todos los sexos · Actualizado el 28 oct 2025 · NCT00898638Evaluating the Use of Dual Imaging Techniques for Detection of Disease in Patients With Head and Neck Cancer
- Vanderbilt University/Ingram Cancer Center, Nashville
ReclutandoFase 1
Edades de 19 en adelante · Todos los sexos · Actualizado el 3 oct 2025 · NCT05945875A Study to Evaluate TROP2 ADC LCB84 Single Agent and in Combination With an Anti-PD-1 Ab in Advanced Solid Tumors
- Tennessee Oncology, Nashville
ReclutandoFase 1/2
Edades de 18 en adelante · Todos los sexos · Actualizado el 24 sept 2025 · NCT05941507Study of Safety and Tolerability of BCA101 Monotherapy and in Combination Therapy in Patients With EGFR-driven Advanced Solid Tumors
- Vanderbilt University Medical Center, Nashville
ReclutandoFase 1
Edades de 18 en adelante · Todos los sexos · Actualizado el 15 ago 2025 · NCT04429542De ClinicalTrials.gov, datos obtenidos el 5 oct 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.